Notably, FAT/CD36 (fatty acid translocation enzymes) promote fatty acid uptake by bone and liver tissues, which are significantly elevated in patients with obesity and NAFLD (Greco et al., 2008; Fabbrini et al., 2009). Here, CD36 is linked to metabolic dysfunction-associated steatotic liver disease.